Hims was founded in 2017 by Andrew Dudum and Jack Abraham. In an October 2020 press release, the company announced its plan to go public through a reverse merger with blank-check company Oaktree Acquisition Corp.
Hims is a telehealth service for men's wellness and care, providing treatment options for hair loss, ED & more. The company has raised nearly $200 million in Venture Capital funding from investors including DCM Ventures, Define Ventures, Material Companies, McKesson Ventures, Next Play Capital, NewView Capital, TriplePoint Venture Growth, Rx3 Ventures, 7 Global Capital, Maverick Ventures, IVP, Forerunner Ventures, and Thrive Capital. It has been widely reported that Hims last raised $100 million in February 2019 at a post-money valuation of $1 billion.
Hims is privately held company and is not publicly traded, therefor investing in Hims pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.
To determine the value of your Hims shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Hims shares. You can also learn more about how to sell your private shares before getting started.
Yes, you can seek to sell shares in Hims while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.